# Praluent

NDC: 61755-021
Generic name: alirocumab
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20201201

FDA application: BLA125559

## Active ingredients

- ALIROCUMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7bcfbac2-e8ac-4569-8edc-bcde3b1fd172